Literature DB >> 25014453

[Endothelial junctions: exploiting their instability in the development of biomarkers for vascular remodelling].

Laurence Bouillet1, Adama Sidibé2, Helena Polena3, Tiphaine Mannic4, Alban Deroux5, Barry Stidder3, Olivier Vittecoq6, Isabelle Vilgrain3.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25014453     DOI: 10.1051/medsci/20143006012

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


× No keyword cloud information.
  1 in total

1.  The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma.

Authors:  Helena Polena; Julie Creuzet; Maeva Dufies; Adama Sidibé; Abir Khalil-Mgharbel; Aude Salomon; Alban Deroux; Jean-Louis Quesada; Caroline Roelants; Odile Filhol; Claude Cochet; Ellen Blanc; Céline Ferlay-Segura; Delphine Borchiellini; Jean-Marc Ferrero; Bernard Escudier; Sylvie Négrier; Gilles Pages; Isabelle Vilgrain
Journal:  Br J Cancer       Date:  2018-03-22       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.